(Q38563384)

4 September 2017

1 reference

title

Maternal antibodies and infant immune responses to vaccines (English)

1 reference

4 September 2017

1

Kathryn M Edwards

1 reference

4 September 2017

language of work or name

English

0 references

publication date

6 August 2015

1 reference

4 September 2017

1 reference

4 September 2017

volume

33

1 reference

4 September 2017

issue

47

1 reference

4 September 2017

page(s)

6469-6472

1 reference

Elevation of Cord over Maternal IgG Immunoglobulin: Evidence for an Active Placental IgG Transport

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Maternal vaccination: moving the science forward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Measles vaccination in the presence of maternal antibodies primes for a balanced humoral and cellular response to revaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Immunological impact of an additional early measles vaccine in Gambian children: responses to a boost at 3 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Increased long term mortality associated with rash after early measles vaccination in rural Senegal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Child mortality after high-titre measles vaccines: prospective study in Senegal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Passive immunity to measles in the breastmilk and cord blood of some nigerian subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Loss of passively acquired maternal antibodies in highly vaccinated populations: an emerging need to define the ontogeny of infant immune responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Early waning of maternal measles antibodies in era of measles elimination: longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

The relationship between concentration of specific antibody at birth and subsequent response to primary immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Influence of maternal antibody against hepatitis B surface antigen on active immune response to hepatitis B vaccine in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Age- and dose-interval-dependent antibody responses to inactivated poliovirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Maternal immunization with pneumococcal 9-valent conjugate vaccine and early infant otitis media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Safety and immunogenicity of trivalent inactivated influenza vaccine in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.07.085

10.1016/J.VACCINE.2015.07.085

7 January 2021

Identifiers

DOI

1 reference

4 September 2017

1 reference